The World Health Organization issued an emergency use listing (EUL) for NuvaxovidTM, following its assessment and approval by the European Medicines Agency (EMA) earlier today.The new vaccine was developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), and is the originator product for the CovovaxTM vaccine that received WHO emergency use listing on 17 December.Both …
https://www.who.int/news/item/21-12-2021-who-lists-10th-covid-19-vaccine-for-emergency-use-nuvaxovid